Goldman Sachs’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-240,435
| Closed | -$9.53M | – | 6028 |
|
|
2024
Q1 | $9.53M | Buy |
240,435
+42,491
| +21% | +$1.25M | ﹤0.01% | 2496 |
|
|
2023
Q4 | $3.77M | Buy |
197,944
+131,499
| +198% | +$1.83M | ﹤0.01% | 3395 |
|
|
2023
Q3 | $761K | Buy |
66,445
+10,670
| +19% | +$131K | ﹤0.01% | 4431 |
|
|
2023
Q2 | $573K | Buy |
55,775
+24,918
| +81% | +$225K | ﹤0.01% | 4666 |
|
|
2023
Q1 | $238K | Buy |
30,857
+368
| +1% | +$2.93K | ﹤0.01% | 5222 |
|
|
2022
Q4 | $224K | Buy |
30,489
+6,550
| +27% | +$41.9K | ﹤0.01% | 5255 |
|
|
2022
Q3 | $172K | Sell |
23,939
-18,977
| -44% | -$156K | ﹤0.01% | 5533 |
|
|
2022
Q2 | $365K | Buy |
42,916
+20,066
| +88% | +$173K | ﹤0.01% | 5299 |
|
|
2022
Q1 | $205K | Buy |
22,850
+9,471
| +71% | +$81.9K | ﹤0.01% | 5873 |
|
|
2021
Q4 | $185K | Buy |
+13,379
| New | +$166K | ﹤0.01% | 5936 |
|
|
2021
Q2 | – | Sell |
-10,577
| Closed | -$112K | – | 6597 |
|
|
2021
Q1 | $112K | Buy |
+10,577
| New | +$132K | ﹤0.01% | 5813 |
|
|
2017
Q1 | – | Sell |
-10,533
| Closed | -$94K | – | 7062 |
|
|
2016
Q4 | $94K | Sell |
10,533
-8,723
| -45% | -$174K | ﹤0.01% | 6171 |
|
|
2016
Q3 | $626K | Buy |
19,256
+12,425
| +182% | +$303K | ﹤0.01% | 4825 |
|
|
2016
Q2 | $126K | Buy |
6,831
+1,664
| +32% | +$29.5K | ﹤0.01% | 6001 |
|
|
2016
Q1 | $86K | Sell |
5,167
-87,298
| -94% | -$1.75M | ﹤0.01% | 6150 |
|
|
2015
Q4 | $2.86M | Sell |
92,465
-828
| -0.9% | -$28.3K | ﹤0.01% | 3319 |
|
|
2015
Q3 | $4.84M | Sell |
93,293
-4,836
| -5% | -$318K | ﹤0.01% | 2915 |
|
|
2015
Q2 | $5.95M | Buy |
+98,129
| New | +$5.84M | ﹤0.01% | 2821 |
|